2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | ||
Interest Income | 601,081,000 | 10.751% | 542,731,000 | 493,471,000 | 458,431,000 | 421,570,000 | |
Interest Expense | (310,660,000) | 28.079% | (242,554,000) | (210,114,000) | (191,422,000) | (183,938,000) | |
Net Interest Income | 290,421,000 | -3.250% | 300,177,000 | 283,357,000 | 267,009,000 | 237,632,000 | |
Other Operating Income | 75,373,000 | 19.606% | 63,018,000 | 82,897,000 | 72,765,000 | 86,835,000 | |
Total Operating Income | 365,794,000 | 0.716% | 363,195,000 | 366,254,000 | 339,774,000 | 324,467,000 | |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 | |
Net Operating Income | 365,794,000 | 0.716% | 363,195,000 | 366,254,000 | 339,774,000 | 324,467,000 | |
Operating Expenses | (107,678,000) | 5.847% | (101,730,000) | (116,691,000) | (108,043,000) | (105,153,000) | |
Impairment Losses on Loans & Advances | (96,768,000) | 4.303% | (92,776,000) | (92,011,000) | (81,782,000) | (71,418,000) | |
Other Impairment Losses | (5,612,000) | -56.053% | (12,770,000) | (4,130,000) | (17,392,000) | (2,009,000) | |
Operating Profit | 155,736,000 | -0.117% | 155,919,000 | 153,422,000 | 132,557,000 | 145,887,000 | |
Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 | |
Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 | |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 | |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 | |
Share of Results of Asso. & JCEs | 233,000 | 79.231% | 130,000 | 116,000 | (2,000) | (25,000) | |
Profit / (Loss) before Taxation | 155,969,000 | -0.051% | 156,049,000 | 153,538,000 | 132,555,000 | 145,862,000 | |
Taxation | (22,138,000) | -18.807% | (27,266,000) | (30,705,000) | (23,365,000) | (23,490,000) | |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
Non-controlling Interests | (597,000) | 1825.806% | (31,000) | (555,000) | (356,000) | (927,000) | |
Others | (4,703,000) | -3.903% | (4,894,000) | (4,894,000) | (2,200,000) | -- | |
Profit / (Loss) Attributable to Shareholders | 128,531,000 | 3.773% | 123,858,000 | 117,384,000 | 106,634,000 | 121,445,000 | |
Depreciation & Amortisation | 10,785,000 | 6.183% | 10,157,000 | 9,663,000 | 9,457,000 | 9,188,000 | |
Directors' Emoluments | -- | -- | -- | -- | -- | -- | |
Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
EPS (cts) | 37.000 | -- | 35.000 | 34.000 | 30.000 | 34.000 |
DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
NBV per share ($) | 6.727 | -- | 6.256 | 5.760 | 5.949 | 4.951 |
Remarks: | Real time quote last updated: 28/06/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (M¥) | RMB 255,421 |
%Change | 2.995% |
EPS / (LPS) | RMB 0.720 |
NBV Per Share (¥) | RMB 7.112 |